Peter Michael Vestlev
Impact in
-
- Vascular Tumors and Angiosarcomas
- Cancer Treatment and Pharmacology
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
-
- Sarcoma Diagnosis and Treatment
Papers in
- Oncology 9
- Cancer Treatment and Pharmacology 4
- HER2/EGFR in Cancer Research 3
- Cancer Diagnosis and Treatment 2
- Bone health and treatments 2
- Colorectal Cancer Treatments and Studies 2
-
- Lung Cancer Treatments and Mutations 3
- Co-authors
- T. Wagener (1 shared paper)H.T. Mouridsen (1 shared paper)Andrés Poveda (1 shared paper)D. Thomas (1 shared paper)Richard Sylvester (1 shared paper)J. Buesa (1 shared paper)A.T. van Oosterom (1 shared paper)William P. Steward (1 shared paper)
In The Last Decade
Peter Michael Vestlev
12 papers receiving 155 citations
Peers
Comparison fields: 5 of 30
- Oncology 76
- Pulmonary and Respiratory Medicine 82
- Cancer Research 34
- Cardiology and Cardiovascular Medicine 25
- Gastroenterology 5
Countries citing papers authored by Peter Michael Vestlev
This map shows the geographic impact of Peter Michael Vestlev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Michael Vestlev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Michael Vestlev more than expected).
Fields of papers citing papers by Peter Michael Vestlev
This network shows the impact of papers produced by Peter Michael Vestlev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Michael Vestlev. The network helps show where Peter Michael Vestlev may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Michael Vestlev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 85 | |
| 2 | 2017 | 47 | |
| 3 | 2020 | 9 | |
| 4 | 2020 | 7 | |
| 5 | 1992 | 3 | |
| 6 | 2022 | 2 | |
| 7 | Forebyggelse af skeletrelaterede hændelser hos patienter med knoglemetastaser ved solide tumorer | 2014 | 2 |
| 8 | 2020 | 1 | |
| 9 | 2021 | 1 | |
| 10 | 2015 | 1 | |
| 11 | 2014 | 1 | |
| 12 | [Prevention of skeletal related events in patients with bone metastases from solid tumours]. | 2014 | 1 |
| 13 | 2025 | 0 | |
| 14 | Is metronomic chemotherapy less toxic than conventional chemotherapy in the randomized phase 2 XeNa trial combining navelbine oral and Xeloda for HER2 negative breast cancer patients | 2015 | 0 |
About Peter Michael Vestlev
Peter Michael Vestlev is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Surgery, having authored 14 papers that have together received 160 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Lung Cancer Treatments and Mutations (3 papers), HER2/EGFR in Cancer Research (3 papers), Cancer Genomics and Diagnostics (2 papers), Cancer Diagnosis and Treatment (2 papers), Breast Cancer Treatment Studies (2 papers), Bone health and treatments (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Oncology (76 citations), Pulmonary and Respiratory Medicine (82 citations), Cancer Research (34 citations), Cardiology and Cardiovascular Medicine (25 citations) and Gastroenterology (5 citations). Peter Michael Vestlev has collaborated with scholars based in Denmark, Spain and Germany. Frequent co-authors include T. Wagener, H.T. Mouridsen, Andrés Poveda, D. Thomas, Richard Sylvester, J. Buesa, A.T. van Oosterom, William P. Steward, Jaap Verweij and Erik Jakobsen. Their work appears in journals such as Acta Oncologica, Journal of Clinical Oncology, Cancer Research, Investigational New Drugs and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.